Inventor

CIECHANOVER AARON

IL8 patents

⚠️ This page may combine multiple inventors who share the name “CIECHANOVER AARON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIGNAL PHARM INC

2 patents

US5932425AAug 3, 1999

Compositions and methods for modulating cellular NF-κB activation

SIGNAL PHARM INC35 citations90

US6656713B2Dec 2, 2003

Compounds and methods for modulating activation of NF-κB

SIGNAL PHARM INC14 citations89

TECHNION RES & DEV FOUNDATION

2 patents

US12421510B2Sep 23, 2025

Peptide, a complex and a method for treating cancer

TECHNION RES & DEV FOUNDATION0 citations49

US11452759B2Sep 27, 2022

Ubiquitin ligase KPC1 promotes processing of P105 NF-κB1 to p50, eliciting strong tumor suppression

TECHNION RES & DEV FOUNDATION0 citations48

SIGNAL PHARM LLC

1 patent

US7186503B2Mar 6, 2007

Compounds and methods for modulating activation of NF-κB

SIGNAL PHARM LLC2 citations59

SIGNAL PHARMACEUTICALS

1 patent

US7414120B2Aug 19, 2008

Compounds and methods for modulating activation of NF-κB

SIGNAL PHARMACEUTICALS2 citations58

RAPPAPORT FAMILY INST FOR RES

1 patent

US7507788B2Mar 24, 2009

Peptides and methods for cell death regulation

RAPPAPORT FAMILY INST FOR RES0 citations43

MANNING ANTHONY M

1 patent

US8263326B2Sep 11, 2012

Compounds and methods for modulating activation of NF-κB

MANNING ANTHONY M0 citations42